Zydus Wellness Limited has informed the Exchange regarding a press release dated May 19, 2025, titled "Press Release".
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Wellness reported a strong FY25, with consolidated net sales growing 16.2% to ₹26,912 million and net profit (excluding exceptional items and one-time deferred tax assets) rising 30% to ₹3,410 million. EBITDA for the year was up 23.2% at ₹3,797 million. For Q4 FY25, net sales grew 17% YoY to ₹9,106 million, adjusted PAT grew 14.4% to ₹1,719 million, and EBITDA rose 17.1% to ₹1,900 million. The Personal Care segment grew 33.4% for FY25 and 22.5% for Q4, while Food and Nutrition grew 13% for FY25 and 15.4% for Q4. Key brands Sugar Free (95.9% share), Glucon-D (58.8% share), Nycil (33.8% share), and Everyuth Scrub (48.5% share) maintained leadership in their categories. The recently acquired Naturell (India) is performing as expected. A weak spot was the Nutrition Drink category declining 2.1% at MAT level, with Complan's share at just 4%.
Positive for shareholders — broad-based double-digit growth in revenue, profit, and EBITDA across both segments, with strong brand franchises reinforcing market leadership. The drag in the Nutrition Drinks category and weak Complan's share are the only minor concerns, but overall results signal healthy momentum.